Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Caution urged in Medical Devices Directive review

This article was originally published in Clinica

Executive Summary

While there are calls from legislators throughout Europe to use the current five-year review of the European Union's Medical Devices Directive (MDD) to tighten requirements for testing and certification bodies, some sections of industry are starting to advocate more caution. Calls for only a few amendments to the MDD, not a universal overhaul, and for regulators to be circumspect about increasing the depth and intensity of notified body assessments are beginning to be heard.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070824

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel